General
Study demonstrates potential of long-acting pasireotide in Cushing’s disease | News for Doctor, Nurse, Pharmacist | Multidisciplinary | MIMS Malaysia
 

Study demonstrates potential of long-acting pasireotide in Cushing’s disease | News for Doctor, Nurse, Pharmacist | Multidisciplinary | MIMS Malaysia

Shared by:

 
Study demonstrates potential of long-acting pasireotide in Cushing’s disease | MIMS Malaysia
 
specialty.mims.com
 
14 Nov 2017 - General
 
Madhubabu kaaja I feel sad to hear that pasireotide is still not widely available in your area. It has shown a lot of promise for the treatment of Cushing syndrome in those who did not have a favorable response to surgery. Pasireotide is supposedly available in the Philippines priced at 1100 PHP (roughly $22 USD) per tablet. I am not sure if it is readily available here too. Maybe someone in the MIMS community fro...
 (Total 83 words)
Surgical excision of the tumor is the definitive management of pituitary adenoma leading to Cushing's disease. Symptom and cortisol control are some of the hallmarks of a successful surgical. In some instances, surgical intervention fails and repeat surgical procedure is contemplated. This update shows that repeat surgery should not be the primary consideration after a failed surgical procedure. Injection with pasireotide IM once monthly has been shown to be more effective than repeat surger...
 (Total 96 words)